UnitedHealth Group reported strong full-year and Q4 results, surpassing earnings expectations with significant revenue and EPS growth. Management provided optimistic guidance for 2020, emphasizing continued growth in Medicare Advantage and cost-containment measures. The positive performance and confident outlook are likely to boost investor sentiment in the short term.

[1]